This is the authors' abstract. We don't add key points for this paper.
// Zhiqiang Zhang 1, * , Jinyi Lang 2, * , Zhi Cao 3 , Rong Li 4 , Xingyong Wang 1 , Weidong Wang 2 1 Department of Critical Care Medicine, Children’s Hospital of Chongqing Medical University, Chongqing 400014, China 2 Department of Radiation Oncology, Sichuan Cancer Hospital, Chengdu 610041, China 3 Department of Radiation Oncology, Sichuan Oncology Institute of Guangxi Medical University, Chengdu 610041, China 4 Institute of Combined Injuries, College of Military Preventive Medicine, Third Military Medical University, Chongqing 400038, China * These authors contributed equally to this work Correspondence to: Weidong Wang, email: wangwd_01@163.com Keywords: superoxide dismutase 2, colorectal cancer, early growth response gene-1, promoter, radiation Received: July 02, 2016 Accepted: December 05, 2016 Published: December 15, 2016 ABSTRACT This study investigated whether radiation-induced overexpression of superoxide dismutase 2 (SOD2) exerts radio-sensitizing effects on tumor cells while having radio-protective effects on normal cells during radio-activated gene therapy for human colorectal cancer. A chimeric promoter, C 9 BC, was generated by directly linking nine tandem CArG boxes to a CMV basic promoter, after which lentiviral vectors containing GFP and SOD2 gene driven by the C 9 BC promoter were constructed. Stably transfected HT-29 colorectal cancer cells and CCD 841 CoN normal colorectal cells were irradiated to a dose of 6-Gy, and cell proliferation and apoptosis were observed. Tumor xenografts and peritumoral skin tissue in BALB/c mice were infected with the therapeutic lentivirus and subsequently irradiated with a total dose of 6 Gy. In vitro experiments revealed that radiation-induced SOD2 overexpression inhibited tumor cell proliferation (61.89% vs. 40.17%, P < 0.01) and decreased apoptosis among normal cells (14.8% vs. 9.6%, P = 0.02) as compared to untransfected cells. Similar effects were observed in vivo . Thus radiation-induced SOD2 overexpression via the chimeric C 9 BC promoter increased the radiosensitivity of HT-29 human colorectal cancer cells and concurrently protected normal CCD 841 CoN colorectal cells from radiation damage.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: